Key statistics
As of last trade, Addex Therapeutics Ltd (APE:FRA) traded at 0.037, 1,133.33% above the 52 week low of 0.003 set on May 06, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.037 |
---|---|
High | 0.037 |
Low | 0.037 |
Bid | 0.059 |
Offer | 0.07 |
Previous close | 0.037 |
Average volume | 1.26k |
---|---|
Shares outstanding | 184.35m |
Free float | 148.78m |
P/E (TTM) | -- |
Market cap | 10.91m CHF |
EPS (TTM) | -0.0534 CHF |
Data delayed at least 15 minutes, as of Jul 15 2025 08:08 BST.
More ▼
Announcements
- Addex Leads CHF 2 Million Investment in Stalicla to Advance Precision Medicine in Neuropsychiatric Disorders
- Addex Shareholders Approve All Resolutions at Annual General Meeting
- Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update
- Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025
- Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models
- Addex to Present Positive GABAB PAM Chronic Cough Data at the 10th American Cough Conference
- Addex Convenes Annual General Meeting 2025
- Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies
- Addex Enters Option Agreement with Sinntaxis for an Exclusive License to Intellectual Property Covering the Use of mGlu5 Inhibitors in Brain Injury Recovery
- Addex Reports Full Year 2024 Financial Results and Provides Corporate Update
More ▼